Speakers

Expand/Collapse

Thomas H. Pedersen
Chief Executive Officer
NMD Pharma

Jane Larkindale
Executive Director, Duchenne Regulatory Science Consortium
Critical Path Institute

Satish Eraly
Medical Director
Biogen

Shazia Ahmad
Director, Patient & Physician Services
UBC

Kenneth Attie
Vice President, Medical Research
Acceleron Pharma

Kirsten Gruis
Global Head, Neuromuscular
Roche

Nicolas Currier
Associate Medical Director
Biogen

Stuart Peltz
Founder & Chief Executive Officer
PTC Therapeutics

Rajasekhar Suragani
Director of Preclinical & Translational Exploratory Biology
Acceleron Pharma

Ralph Kern
Executive Vice President, Chief Operating Officer & Chief Medical Officer
Brainstorm Cell Therapeutics

Laurie Conklin
Medical & Regulatory Director
ReveraGen Biopharma

Keith Foster
Chief Scientific Officer
Sutura Therapeutics

Susan Ward
Head of Clinical Operations
Brainstorm Cell Therapeutics

Eva Chin
Director
Cytokinetics

Kenneth Rhodes
Chief Scientific Officer
Yumanity Therapeutics

Mathieu Nonnenmacher
Principal Scientist, Vector Engineering
Voyager Therapeutics

Elin Haf Davies
Research Fellow
Bangor University

Romesh Subramanian
CEO & Founder
Dyne Therapeutics